Taiwan’s retail landscape is being reshaped by consumers who no longer distinguish between digital and physical shopping. In this maturing market, winning depends on seamless execution across every touchpoint.
A historic surge in AI-related exports has powered Taiwan’s economy to stunning highs, but rising U.S. protectionism, domestic strains, and questions about long-term competitiveness reveal just how challenging 2026 may be.
Record revenues and rising adoption in Taiwan underscore Coupang’s growing influence in the local e-commerce market, though analysts note that competitive pressure, sourcing challenges, and the limits of subsidy-driven expansion could shape its next phase.
A decade of research in Taiwan is reshaping how pancreatic cancer is detected and treated, combining innovative therapies with breakthrough AI diagnostics. These advances are opening new possibilities for earlier intervention and longer survival.
Taiwan is placing vaccination at the heart of its Healthy Taiwan agenda, treating prevention as essential to easing pressure on the healthcare system.
Taiwan’s fast-food market has become a proving ground where global brands and homegrown chains test new formats, technologies, and flavors that increasingly shape regional and international trends.
TAPPL and Catch, two island-born chocolate bars with unexpectedly different origins, have become enduring favorites in Taiwan’s candy aisles through nostalgia, affordability, and distinctive flavor profiles.
Taiwan’s textile industry is reinventing itself through AI, sustainability, and design, turning traditional manufacturing into a high-value, data-driven ecosystem shaping the future of global textiles.
As Nike weathers its longest slump in years, Taiwan’s sneaker supply chain faces pressure to adapt — turning to rising stars like On and Hoka, as well as smarter, more sustainable manufacturing, to stay ahead of China’s fast-advancing competitors.
Taiwan’s researchers are uncovering the genetic roots of lung cancer among non-smokers, positioning the island as a leader in precision oncology, though regulatory and funding hurdles still slow the path from discovery to care.
